HBIO Q1 2026 Earnings Loss Narrower Than Expected on Cost Controls Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development ANVS Q1 2026 Earnings WiderthanExpected Loss Reflects SteppedUp RD Investment YDKG Q4 2012 Earnings EPS Misses Estimates Amid Challenging Quarter PAPL Q3 2025 Earnings EPS Surprises Significantly Above Estimates Despite Stock Decline